Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry.
J Cardiovasc Pharmacol. 2022 Apr 1;79(4):523-529. doi: 10.1097/FJC.0000000000001205.
J Cardiovasc Pharmacol. 2022.
PMID: 34983910
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Cordero A, Fernández Olmo MR, Cortez Quiroga GA, Romero-Menor C, Fácila L, Seijas-Amigo J, Rondán Murillo J, Sandin M, Rodríguez-Mañero M, Bello Mora MC, Valle A, Fornovi A, Freixa Pamias R, Bañeras J, Blanch García P, Clemente Lorenzo MM, Sánchez-Álvarez S, López-Rodríguez L, González-Juanatey JR.
Cordero A, et al. Among authors: fornovi a.
Eur J Clin Invest. 2022 Dec;52(12):e13863. doi: 10.1111/eci.13863. Epub 2022 Sep 5.
Eur J Clin Invest. 2022.
PMID: 36039486
Item in Clipboard
Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.
Pujante P, Hellín MD, Fornovi A, Martínez Camblor P, Ferrer M, García-Zafra V, Hernández AM, Frutos MD, Luján-Monpeán J, Tébar J.
Pujante P, et al. Among authors: fornovi a.
Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):812-8. doi: 10.1016/j.rec.2013.05.018. Epub 2013 Aug 2.
Rev Esp Cardiol (Engl Ed). 2013.
PMID: 24773862
Item in Clipboard
Cite
Cite